Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp); A phase II trial in progress

被引：0
|
作者：
Paik, P. [1 ]
Sakai, H. [2 ]
Bruns, R. [3 ]
Scheele, J. [4 ]
Straub, J. [5 ]
Felip, E. [6 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[2] Saitama Canc Ctr, Dept Thorac Oncol, Saitama, Japan
[3] Merck KGaA, Biostat, Darmstadt, Germany
[4] Merck KGaA, Clin Oncol, Darmstadt, Germany
[5] Merck KGaA, Global Early Dev, Darmstadt, Germany
[6] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
546TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Comparison of Utility Values Generated Using Different Methods From the Phase II Vision Trial of Tepotinib for Patients With Non-Small Cell Lung Cancer (NSCLC) Harboring MET Exon 14 (METex14) Skipping
    Hook, E.
    Vioix, H.
    Batteson, R.
    McLean, T.
    Hatswell, A.
    VALUE IN HEALTH, 2022, 25 (12) : S420 - S420
  • [22] A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
    Santarpia, Mariacarmela
    Massafra, Marco
    Gebbia, Vittorio
    D'Aquino, Antonio
    Garipoli, Claudia
    Altavilla, Giuseppe
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1536 - +
  • [23] Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping.
    Kato, Terufumi
    Yang, James Chih-Hsin
    Ahn, Myung-Ju
    Sakai, Hiroshi
    Morise, Masahiro
    Chen, Yuh-Min
    Han, Ji-Youn
    Yang, Jin-Ji
    Zhao, Jun
    Huang, Jason
    Berghoff, Karin
    Bruns, Rolf
    Vioix, Helene
    Otto, Gordon
    Le, Xiuning
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping
    Yang, J. C-H.
    Le, X.
    Cho, B. C.
    Han, J-Y.
    Morise, M.
    Chen, Y-M.
    Kang, J-H.
    Kato, T.
    Takeoka, H.
    Chikamori, K.
    Sakai, H.
    Park, K.
    Wu, Y-L.
    Schumacher, K.
    Bruns, R.
    Straub, J.
    Paik, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1390 - S1391
  • [25] Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial
    Morise, Masahiro
    Sakai, Hiroshi
    Veillon, Remi
    Le, Xiuning
    Felip, Enriqueta
    Garassino, Marina Chiara
    Cortot, Alexis B.
    Smit, Egbert
    Park, Keunchil
    Griesinger, Frank
    Britschgi, Christian
    Wu, Yi-Long
    Berghoff, Karin
    Otto, Gordon
    Bruns, Rolf
    Paik, Paul
    ANNALS OF ONCOLOGY, 2021, 32 : S291 - S291
  • [26] Phase II Data for the MET Inhibitor Tepotinib in Patients with Advanced NSCLC and MET Exon 14-Skipping Mutations
    Felip, E.
    Sakai, H.
    Patel, J.
    Horn, L.
    Veillon, R.
    Griesinger, F.
    Bruns, R.
    Scheele, J.
    Paik, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S347 - S347
  • [27] Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial
    Veillon, R.
    Sakai, H.
    Le, X.
    Felip, E.
    Garassino, M. C.
    Cortot, A.
    Smit, E.
    Park, K.
    Griesinger, F.
    Britschgi, C.
    Wu, Y.
    Berghoff, K.
    Otto, G.
    Bruns, R.
    Paik, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S231 - S231
  • [28] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Huang, Caiwen
    Zou, Qihua
    Liu, Hui
    Qiu, Bo
    Li, Qiwen
    Lin, Yongbin
    Liang, Ying
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [29] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Caiwen Huang
    Qihua Zou
    Hui Liu
    Bo Qiu
    Qiwen Li
    Yongbin Lin
    Ying Liang
    Current Treatment Options in Oncology, 2020, 21
  • [30] Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer
    Ahn, Linda
    Alexander, Terri
    Vlassak, Soetkin
    Berghoff, Karin
    Lemmens, Liesbeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (05) : 543 - 551
12345